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KCC2 is a neuron specific K+-Cl− co-transporter that controls neuronal chloride homeostasis, and 
is critically involved in many neurological diseases including brain trauma, epilepsies, autism and 
schizophrenia. Despite significant accumulating data on the biology and electrophysiological properties 
of KCC2, structure-function relationships remain poorly understood. Here we used calixarene detergent 
to solubilize and purify wild-type non-aggregated and homogenous KCC2. Specific binding of inhibitor 
compound VU0463271 was demonstrated using surface plasmon resonance (SPR). Mass spectrometry 
revealed glycosylations and phosphorylations as expected from functional KCC2. We show by electron 
microscopy (EM) that KCC2 exists as monomers and dimers in solution. Monomers are organized into 
“head” and “core” domains connected by a flexible “linker”. Dimers are asymmetrical and display a bent 
“S-shape” architecture made of four distinct domains and a flexible dimerization interface. Chemical 
crosslinking in reducing conditions shows that disulfide bridges are involved in KCC2 dimerization. 
Moreover, we show that adding a tag to the C-terminus is detrimental to KCC2 function. We postulate 
that the conserved KCC2 C-ter may be at the interface of dimerization. Taken together, our findings 
highlight the flexible multi-domain structure of KCC2 with variable anchoring points at the dimerization 
interface and an important C-ter extremity providing the first in-depth functional architecture of KCC2.
Fast inhibitory neurotransmission in the central nervous system (CNS) is mediated by GABA and glycine via 
ligand-gated Cl− channels. KCC2 is a neuron specific potassium-chloride co-transporter that is critically impli-
cated in several neurological diseases including brain trauma, certain types of epilepsies and neuropathic pain1. 
KCC2 extrudes chloride, maintains low intracellular chloride concentration and renders GABA and glycine 
action hyperpolarizing in mature neurons2–6. The molecular mechanism of KCC2 function is not fully under-
stood. Based on hydropathy analysis of the KCC2 protein, a model of KCC2, including 12 transmembrane 
domains flanked by intracellular N- and C-termini was proposed7. Although the information on the functional 
importance of the different structural elements of the KCC2 protein is limited, numerous studies suggest an 
important role of the C-terminus in control of KCC2 activity8. This co-transporter was shown to exhibit vari-
ous posttranslational modifications (PTM) such as glycosylations and phosphorylations linked to function1,9–15. 
In terms of molecular assembly, KCC2 can form oligomers in an age-dependent manner as immature brains 
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were characterized by a higher content of monomers, whereas adult tissue produced mostly oligomeric forms of 
KCC29. An additional set of data demonstrating the ability of KCC2 to form dimers in vivo came from studies 
describing the distribution16 and interaction17 between KCC2a and KCC2b isoforms18. Uvarov and colleagues 
(2009) have shown that KCC2a and KCC2b isoforms form homo- and heterodimers in vivo in heterologous 
HEK293 cells. Despite the high interest in this protein due to its involvement in different neurological indications, 
structure-function of KCC2 remains poorly understood. To this end, it is critical to produce large amount of 
functional purified KCC2 to investigate its assembly, PTM and structure. Here, we characterized a set of tagged 
human KCC2 constructs and found that the addition of peptide tags to the C-terminus of KCC2 completely abol-
ished its transporter activity. This first functional architecture of KCC2 will certainly serve for structure based 
drug design, fragment based drug discovery and antibody development towards the treatment of CNS disorders.
Results
Functional expression of KCC2. In order to produce a large amount of purified KCC2, we expressed dif-
ferent constructs of the wild type sequence (Untagged KCC2, Flag-KCC2-His, Flag-Avi-His-KCC2 and KCC2-
His-Avi-Flag) in HEK293 cells. To evaluate the functionality of the wild type sequence constructs, we used the 
thallium (Tl+) flux assay. As previously described19, this method is based on the use of Tl+ as a potassium (K+) 
tracer. This assay relies on the ability of KCC2 to act either in influx or efflux mode according to the ion gradients 
present, combined with the ability of thallium to be transported by potassium transporters. Cells challenged 
with a high concentration of Tl+ and K+ were used to assess KCC2 influx activity using a fluorescent assay read-
out. Fluorescence is generated when Tl+ binds to a pre-loaded Tl+ sensitive dye inside the cell. HEK293 cells 
expressing untagged or amino-terminal Flag-Avi-His-tagged KCC2, displayed Tl+ flux in this assay (Fig. 1A). 
The flux could be reduced to background levels comparable to untransfected cell by the addition of the KCC2-
specific transporter inhibitor VU0463271 (N-cyclopropyl-N-(4-methyl-2-thiazolyl)-2-[(6-phenyl-3-pyridazinyl) 
thioacetamide). N-ethylmaleimide (NEM) is known to stimulate KCC2 activity and addition of NEM to these 
cells resulted in an increase of Tl+ flux. The enhanced Tl+ flux was specific to KCC2, with no effect of NEM to 
untransfected cells (Fig. 1A). Interestingly, carboxy-terminal tagged KCC2 did not exhibit any basal activity and 
was not potentiated by NEM in the thallium assay. Thus, the addition of purification tags to the carboxy terminus 
completely abolished transporter activity. To rule out the possibility that these differences in activity are due to 
differences in expression, we analyzed the expression levels by Western-blot. Interestingly, transfected HEK293 
cells for both N- and C-ter constructs showed similar KCC2 signal in Western-blot. No signal was observed for 
KCC2 in untransfected cells. Actin was used as loading control and shows the same signal in Western-blot in all 
conditions (Fig. 1B). To confirm these results, we used gramicidin perforated-patch clamp electrophysiology in 
transfected HEK293 cells. We assessed the functional expression of each construct by measuring VU0463271-
induced shifts in the reversal potential of glycine-activated currents (EGLY) and the calculated [Cl−] values. Both 
the KCC2-WT and Flag-Avi-His-KCC2 exhibited VU0463271-induced positive shifts of EGLY values (Fig. 1C) 
but no VU0463271-induced shifts were observed in cells expressing the KCC2-His-Avi-Flag (Fig. 1D) construct. 
Statistical analysis of EGLY shifts showed a major effect of the construct (Fig. 1E; ANOVA: F = 9.23, p < 0.001) with 
KCC2-His-Avi-Flag (p < 0.01) and Flag-KCC2-His (p < 0.01), but not Flag-Avi-His-KCC2 (p = 0.66, ns), signif-
icantly different from KCC2-WT. These differences were reflected in analysis of [Cl−], with a major effect of the 
transfected construct (Fig. 1F; ANOVA: F = 8.50, p < 0.001) with KCC2-His-Avi-Flag (p < 0.01) and Flag-KCC2-
His (p < 0.01), but not Flag-Avi-His-KCC2 (p = 0.99). Consistent with these observations, KCC2-WT and Flag-
Avi-His-KCC2 expressing cells exhibited chloride extrusion upon washout of VU0463271, further indicating that 
they are functional (data not shown). KCC2 is known to reside both as a plasma membrane localized fraction 
and as a larger pool inside the cell in internal membranes20. To rule out the possibility that differences in KCC2 
activity may correlate with differences in membrane localization, we performed immunofluorescence staining of 
different tagged version of KCC2. Figure S10 shows no alterations in KCC2 localization with the different con-
structs. This was also shown for Cos7 transfected cells (data not shown). These data indicate that the N-terminal 
tagged KCC2 construct is functionally active when expressed in HEK293 cells and was therefore selected for 
further biochemical and structural characterization.
Solubilization and purification of KCC2. Flag-Avi-His-KCC2 (N-KCC2) was produced by transient 
transfection of HEK293 cells at large scale (20 Liters of culture). Cells were lysed by mechanical disruption. 
Membrane fractionation was performed using sequential centrifugation steps at 1000, 15000 and 100,000 x G 
corresponding to non-lysed cells, enriched internal membranes and enriched plasma membranes, respectively. 
The presence of KCC2 in each fraction was analyzed by SDS-PAGE followed by Western-blot using an antibody 
against KCC2 (Fig. 2A). Two main bands were observed at ~140 kDa and ~300 kDa in all fractions. These results 
indicate that KCC2 was present both in the internal and plasma membranes. The observed molecular weight of 
KCC2 of ~140 kDa, is higher than the theoretical molecular weight of ~120 kDa. These ~140 kDa band may cor-
respond to different post-translationally modified populations of KCC2. This is consistent with previous reports 
showing that the glycosylated form of KCC2 migrates at ~140 kDa9,10. The band at 300 kDa may correspond to 
non-dissociated dimers that are SDS-resistant, which is often observed when membrane protein samples are not 
heated prior to gel migration to avoid aggregation and precipitation21,22. Since KCC2 was detected in internal 
and plasma membrane fractions, detergent screening using classical detergents (DDM, OG, Triton, FC12 and 
CHAPS), novel calixarenes based detergents (CALX reagents R1 to R6) or a combination of both was applied 
to both membrane fractions and results were assessed by dot blot using a KCC2 specific antibody. Figure 2B 
shows striking differences in KCC2 solubilization between internal and plasma enriched membrane fractions. 
Indeed, KCC2 from internal membranes was difficult to extract. This may correspond to a misfolded fraction due 
to KCC2 overexpression. On the contrary, plasma membrane KCC2 showed good solubilization mainly when 
calixarene based detergents were used alone (indicated in blue, Fig. 2B and C) or in combination with classical 
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detergents (indicated in red in Fig. 2B and C). Plasma membrane solubilization efficiency is indicated by relative 
intensity quantification of dot blot (Fig. 2C). Dot blot analyses were used to generate first solubilization indica-
tions that needed to be further confirmed. Western-blot analysis confirmed the dot blot results (Fig. 2D). Human 
KCC2 was efficiently solubilized using CALX-R3 (~80% of solubilization yield, Fig. 2D, compare lanes 12 to 10) 
in contrary to DDM. Interestingly, similar solubilization conditions were obtained on mouse KCC2 expressed in 
the neuroblastoma cell line N2a or HEK293 cells (Figure S1). This demonstrates that KCC2 solubilization relies 
Figure 1. Thallium (Tl+) flux, expression of KCC2 constructs, and electrophysiology. (A) Thallium flux of 
untagged KCC2, N-terminal tagged KCC2 (Flag-Avi-His-KCC2), C-terminal tagged KCC2 (KCC2-His-
Avi-Flag), double tagged KCC2 (Flag-KCC2-His) and untransfected cells are shown. Blue = NEM 100 µM, 
Black = DMSO 0.5%, Yellow = VU0463271 10 µM. Multiple blue lines are multiple NEM-treated wells (n = 32 
for each treatment condition). (B) SDS-PAGE and Western-blot using antibody against KCC2 or actin as 
loading control (Sigma A5441 at 1:1000 dilution) in untransfected (lane 1), Flag-Avi-His-KCC2 transfected 
(lane 2) or KCC2-His-Avi-Flag transfected (lane 3) HEK293 cells. 20 µg per lane were loaded. (C) Example leak-
subtracted traces from a Flag-Avi-His-KCC2 expressing HEK293 cells before (blue) and after (red) four-minute 
application of 10 µM VU0463271. (D) Example leak-subtracted traces before (blue) and after (red) VU0463271 
application in a KCC2-His-Avi-Flag expressing HEK293 cell. (E) Summary data showing comparable shifts 
in EGLY and (F) [Cl−] in KCC2-WT and Flag-Avi-His-KCC2, with no consistent shift observed in the KCC2-
His-Avi-Flag-KCC2 or Flag-KCC2-His tagged construct expressing cells. **Indicates a significant difference 
(p < 0.01) in distribution from KCC2-WT. The chloride concentrations were calculated with the Nerst equation 
(see experimental procedure).
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Figure 2. Fractionation and solubilization of native KCC2 from plasma and internal membranes. (A) Presence 
of KCC2 in cell membranes was detected by Western-blot using KCC2 specific antibody after membrane 
fractionation. Cell membrane were separated using sequential centrifugations after lysis of HEK293 cells. P1, 
pellet after centrifugation at 1000 × g (cell debris, whole cells); P2, pellet after centrifugation at 15000 × g (ER, 
mitochondria, nucleus); P3, pellet after centrifugation at 100000 × g (plasma membranes); and S, supernatant 
after centrifugation at 100000 × g. (B) Solubilization screen of KCC2 from internal and plasma membranes 
monitored by dot blot using KCC2 specific antibody. 10 critical micellar concentration (CMC) of each 
detergent, classical (in green, DDM, OG, Triton, FC12 and CHAPS) and calixarenes based detergents (in blue, 
CALX- R1-6), alone or in combination (in red) were used. Solubilization without or with SDS served as negative 
or positive controls, respectively (in orange). The experiment was done 3 times (C) Solubilization efficiency 
representation from relative intensity quantification of dot blot using Image Lab 4.1 software (Bio-Rad). Only 
dot blot from plasma membrane fractions were represented. All signal intensities are normalized to the highest 
signal observed for each dot blot (considered as 100%), n = 3. (D) Classical solubilization of internal and plasma 
membranes using selected conditions from dot blot screening followed by SDS-PAGE and Western-blot using a 
specific KCC2 antibody. Proteins from Total extract (T), pellets (P) and supernatants (S) after centrifugation at 
100000 x g were analyzed. C(−) and C(+) correspond to the buffer (without detergent) and SDS, respectively.
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upon intrinsic common structural features of the 12 TM domains of KCC2 and not on the lipidic composition 
and/ or expression system diversity. We therefore focused on enriched plasma membranes and decided to use 
CALX-R3 as the solubilization reagent for subsequent purification steps. To avoid any possible detergent inter-
ference with the affinity column used for protein purification, we applied a minimal detergent concentration of 
6 CMC (9 mM) which resulted in a KCC2 solubilization of ~80% (data not shown). We decided to use 9 mM of 
CALX-R3 as it was a good compromise between solubilization and detergent concentration. Solubilized material 
was loaded on His-tag affinity resins (Talon and Ni-NTA). The best results were obtained using Ni-NTA for which 
total binding and efficient elution of KCC2 were observed (Fig. 3A). In contrast, talon resin did not result in good 
protein elution (Figure S2A). The purity obtained using Ni-NTA was relatively good (~70%) (Fig. 3C, lane 1) and 
Flag- affinity was applied as a second affinity step to improve purity. Figure 3B shows that the protein could bind 
to magnetic Flag-M2 beads and elute specifically from the resin. This was not the case for agarose Flag M2 resin 
(Figure S2B). Combining Ni-NTA and Flag-M2 purification, improved the purity to ~90% as shown in Fig. 3C 
(compare lane 2 to 1). In summary, KCC2 was solubilized using CALX-R3 from enriched plasma membranes 
fractions and isolated to a high purity using a tandem affinity purification (Ni-NTA and Flag).
Characterization of the oligomeric state and the post-translational modifications of purified 
KCC2. Several members of the cation-chloride cotransporter (CCC) family including KCC2 were reported to 
forms oligomers in vivo23,24. To address whether KCC2 purified from HEK293 plasma membrane fractions forms 
aggregates, oligomers or monomers, the protein was assessed by Native PAGE similarly to previously reported 
work25. Two bands of KCC2 were observed on a Native PAGE (Fig. 4). They may correspond to the monomer 
and dimer, according to the molecular weight of protein markers. No aggregates were observed on Native PAGE 
even after a freeze-thaw cycle in the absence of a cryoprotectant. This illustrates the relative stability of KCC2 
when solubilized and purified using the CALX-R3 compound. Interestingly, recombinant mouse KCC2 purified 
from HEK293 cells using the same solubilization and purification procedures, showed a virtually identical Native 
PAGE profile with a monomer and dimer band, but no aggregates and/ or higher oligomers (Figure S3) suggesting 
a common molecular assembly conserved between mouse and human KCC2. Gel filtration analysis confirmed 
a non-aggregated state of purified human KCC2 with no KCC2 in the void volume fraction and a separation 
between dimeric and monomeric populations shown by Native PAGE (Fig. 4B). The use of DDM to replace 
CALX-R3 reagent for gel filtration resulted in KCC2 aggregates (data not shown). Similar calixarene-based deter-
gents were recently reported to stabilize native forms of membrane proteins21,22,26–28. Thus, we show that KCC2 
purified using CALX-R3 compound exists as monomer and dimer and not higher oligomers or aggregates. To bet-
ter characterize post-translational modifications of KCC2 and to evaluate its glycosylation state, purified protein 
was subjected to PNGase treatment. Figure 5A shows that KCC2 displayed increased mobility after PNGase diges-
tion, demonstrating that purified KCC2 was glycosylated. To evaluate if KCC2 was phosphorylated at well-known 
residue serine 940, we used a specific antibody recognizing phospho-serine 940 (pS940)13,14. Figure 5B shows 
that purified KCC2 was recognized by this antibody similarly to KCC2 antibody. Both KCC2 and pS940-KCC2 
antibodies reveal monomeric and dimeric KCC2 bands suggesting that both monomeric and dimeric KCC2 were 
phosphorylated at serine 940. In order to collect more information about KCC2 post-translational modifications, 
we analyzed purified KCC2 by mass spectrometry after trypsin digestion (Tables S4, Figures S5 and S6). A 44% 
KCC2 sequence coverage was obtained. Detected peptides are listed in Figure S5. It is possible that some of the 
non-detected peptides correspond to transmembrane helices that are difficult to detect by mass spectrometry. As 
suggested by Western-blot analysis, mass spectrometry reveals a heavily glycosylated KCC2 consistent with the 
observed gel shift after PNGase treatment (Fig. 5A). PNGase treatment and mass spectrometry analysis resulted 
in the identification of six glycosylation sites for N283, N291, N310, N328, N338 and N339 (Fig. 5C, Table S4, 
Figures S5 and S6). N291, N310 and N339 are well conserved between KCC2 and KCC4 and were only identified 
Figure 3. Purification of KCC2. CALX-R3 solubilized KCC2 (Flag-Avi-His-tagged on N-ter) was purified by 
(A) Ni-NTA chromatography followed by (B) Flag-affinity (Flag-M2 magnetic beads) and analyzed by SDS-
PAGE and Western-blot (A,B) or silver stain (C). T: Total extract, P: Pellet after centrifugation at 100000 × g, S: 
Supernatant after centrifugation at 100000 × g, I: Input, FT: Flow-Through, W: Wash, E: Elution.
www.nature.com/scientificreports/
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for KCC4 (Table S4). Identified phosphorylation sites were S25, S26, S940, T1007 and S1022. Among those, S1022 
was identified in rat tissues29. S25 and S26 were observed in mouse30. S940 and T1007 has been described and 
directly correlated to KCC2 function11–14 and confirmed by Western-blot in the present work (Fig. 5B). These 
mass spectrometry results show that KCC2 was modified post-translationally on key functional residues.
Functional characterization of purified native KCC2. Given the critical role that KCC2 plays in neu-
ronal function and the growing interest in generating novel selective blockers or activators, we decided to inves-
tigate binding of small molecule compounds to purified KCC2. We took advantage of the N-terminal His-tag of 
KCC2 for immobilization on a Ni-NTA chip to evaluate binding of a selective inhibitor VU0463271. This com-
pound has been previously shown to selectively inhibit KCC2 leading to hyperexcitability and epileptiform dis-
charges in the hippocampal slices31–33. Purified KCC2 could be effectively captured and covalently tethered to the 
biosensor allowing to generate a stable sensor surface for subsequent ligand binding experiments. Ligand-binding 
competence of the tethered material was assessed with the antagonist VU0463271 in a concentration-response 
experiment. Sensorgrams for binding of VU0463271 demonstrates a clear saturation, and an affinity of 3–11 µM 
(Fig. 6). We investigated binding of the antagonist compound VU0463271 to immobilized monomers or dimers 
separated by gel filtration (Fig. 4B). No significant difference in binding was observed for KCC2 monomer and 
dimer (Fig. 6B). The specificity of the binding was assessed using non-specific compound (Fig. 6C). Thus, KCC2 
shows indirect and direct functional evidence by Biacore and electrophysiology/ thallium assays, respectively.
Structural organization of KCC2. In order to investigate the structural organization of purified KCC2, 
we have used negative stain electron microscopy (EM) to analyze the gel filtration fractions of KCC2 monomers 
and dimers. When observed by EM, the KCC2 monomer fraction shows isolated particles about 90–120 Å in size 
(Fig. 7A). A total of 2000 micrographs were recorded and 114,370 particles were selected, aligned and clustered 
into classes. The resulting class averages show different views of the KCC2 monomer which often appears to be 
formed by two domains. (Figure S7-A). A 3-D model was calculated ab initio and the image dataset was clustered 
into 3 classes to reveal heterogeneities or conformational changes of the sample (Fig. 7B). The three classes are 
slightly elongated and are organized into two major domains connected by a linker domain. The smallest “head” 
domain appears to be flexible and adopts different positions as compared to the largest “core” domain. Classes I, 
II and III correspond to 30, 32 and 38% of the monomeric particles, respectively, suggesting that the conforma-
tional changes are continuous. Class I in which the two domains were best resolved was further refined to reach a 
resolution of ~15 Å (Fig. 7C and video S9) as evaluated by Fourier Shell Correlation curves. The EM observation 
of the KCC2 dimer fraction revealed particles about 150–180 Å in size, significantly larger than the monomers 
(Fig. 8A). To gain more insights into the quaternary structure of dimeric KCC2, we recorded 2,000 micrographs 
and selected 78,781 dimeric particles, which were aligned and clustered into different classes. Figure S7-B shows 
the resulting class averages. A 3-D model was calculated ab initio from the dimeric particles and the image dataset 
was clustered into 3 classes to identify distinct conformations (Fig. 8C). As the three classes did not reveal signif-
icant conformational changes, the whole dataset was refined to reach a 3-D model with a resolution of ~17.4 Å 
(Fig. 8B and video S8). The 3-D model of the dimeric fraction has the same overall architecture, consisting of 4 
Figure 4. Homogeneity and stability of purified KCC2. Purified KCC2 was subjected (+) or not (−) to flash-
freezing in liquid nitrogen and then (A) loaded on a 4–15% Tris-glycine Clear Native PAGE and detected by 
KCC2 antibody. (B) Gel filtration profile and corresponding Native PAGE revealed by KCC2 antibody show the 
separation of dimers and monomers of KCC2. *Indicates detergent migration in gel filtration. **Corresponds 
to nonspecific signal not observed in other Native PAGE gels. Void volume is indicated by an arrow and Vo.
www.nature.com/scientificreports/
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Figure 5. Post-translational modifications of KCC2. (A) SDS-PAGE and Western-blot of purified KCC2 treated 
or not with PNGase F using specific antibody against KCC2. (B) SDS-PAGE and Western-blot of purified KCC2 
using an antibody directed against KCC2 Phosphoserine S940 (@pS940) or a specific anti-KCC2 antibody (@
KCC2). Bands corresponding to KCC2 monomer and “SDS resistant” dimer are indicated. (C) Summary of 
mass spectrometry results on PTMs investigation. Secondary structure and topology predictions are indicated.
Figure 6. SPR ligand binding experiments with VU0463271 and KCC2 dimer and monomer. (A) Sensorgrams 
for binding of VU0463271 injected over purified KCC2 sensor surface in a 3-fold dilution series (see experimental 
procedure). (B) Concentration-dependant binding of VU0463271 on immobilized purified KCC2 dimer (red 
circles) and monomer (blue). Langmuir fit yield Kd (dimer) = 4 ± 2 µM (n = 2) and Kd (monomer) = 11 ± 7 µM 
(n = 2). (C) Concentration-dependent binding of VU0463271 (blue diamonds) and non-specific control 
compound (red circles) on immobilized purified KCC2. Langmuir fit yield Kd = 3 ± 2 µM (n = 3).
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Figure 7. Electron microscopy of KCC2 monomers. (A) Negative stain image showing particles of purified 
KCC2 monomers of about 90–120 Å in size and (B) 3D class averages of monomers. Classes I, II and III 
correspond to 30, 32 and 38% of the monomeric particles, respectively. (C) 3D class I in which the two domains 
were best resolved is presented in different views after refinement. Head, core and linker structures are indicated 
by H, C and L, respectively.
Figure 8. Electron microscopy of KCC2 dimers. (A) Negative stain image showing particles of purified KCC2 
dimers of about 150–180 Å in size and (B) 3D class averages of dimers. Classes I, II and III correspond to 30, 32 
and 38% of the dimeric particles, respectively. (C) Different views of refined 3D model are shown. The scale bar 
corresponds to 100, 12.5 and 11 for (A,B and C), respectively.
www.nature.com/scientificreports/
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different structural modules connecting to each other to form an elongated bent “S” shape. A flexible “hinge” 
region observed in all classes may account for a very flexible anchoring dimerization interface between mon-
omers. To test the contribution of disulfide bridges to KCC2 dimerization, we incubated purified KCC2 with 
DTT and then subjected the sample to chemical crosslinking using glutaraldehyde. A good correlation between 
crosslinker concentration and the appearance of the KCC2 dimer band was observed (Fig. 9). Interestingly, the 
presence of DTT results in a significant reduction of dimerization suggesting that disulfide bridges are involved 
in KCC2 dimerization.
Discussion
We show that KCC2 exists as monomers as well as dimers in solution but not trimers, tetramers or higher 
homo-oligomers as previously reported9. One explanation of this discrepancy may be due to misleading SDS 
resistant effect in SDS-PAGE. Our study did not base oligomeric state assessment on SDS-PAGE patterns but 
rather on Native PAGE where SDS-resistant complex artefacts are not observed. In addition, crosslinking experi-
ments in reducing and non-reducing conditions, gel filtration and electron microscopy studies show the presence 
of monomers and dimers. Transporters such as NKCC1 demonstrated a dimeric organization24,34,35, which is con-
sistent with our finding. Our Biacore experiments suggest that both the monomer and dimer are functional but 
further experiments such as mutagenesis of residues at the dimer interface will need to be performed to address 
this question.
Sequence analysis and topology predictions suggest that KCC2 possesses two different structural domains. The 
first could be composed of 12 transmembrane helices (TM) and the second corresponding to a carboxy-terminal 
cytoplasmic domain (C-ter). The first domain is homologous to the glutamate-GABA anti-porter structure 
(PDB: 4DJK), while the C-ter domain displays sequence/ secondary structure homology to the prokaryotic 
cation-chloride cotransporter (PDB: 3G4O). Figure 10A shows a fit of both structures filtered to 12 Å. Additional 
density remains unfitted and may account for linkers and long loops. Two monomers were found to fit well to the 
dimer (Fig. 10B). Other fits are certainly possible and higher resolution Cryo-EM structures will be required to 
better map KCC2 domain organization. Interestingly, the prokaryotic cation-chloride cotransporter was shown 
to dimerize in solution36,37 suggesting that the KCC2 C-ter domain may be at the interface of dimerization. Our 
study demonstrates that in contrast to KCC2 WT and the tagged in N-terminus KCC2, modification of KCC2 at 
the C-terminus by addition of a His-Avi-Flag-tag led to inactivation of the transporter in both thallium assays 
and in electrophysiology assays. Therefore, we propose that the dimerization interface is composed of at least 
two anchor points, one being mediated by disulfide bridges (perhaps between specific extracellular loops present 
on monomers) and the second maybe involving functional homodimerization of the C-ter domain. Figure 10B. 
Further studies on functional investigation (ligand binding and transport) of KCC2 C-terminal mutants are 
needed to confirm that. Purified KCC2 exhibits specific key posttranslational modifications such as glycosylation 
and phosphorylation that have been reported to be required for KCC2 cotransporter activity13,14,25,31. Here, the 
phospho-serine 940 at the intracellular C-terminal domain was specifically recognized by an antibody directed 
against the phosphorylated state of this residue. This was unambiguously confirmed by mass spectrometry. 
Previously reported phosphorylated residues such as S940 and T1007 could be confirmed in the present study. 
S1022 phosphorylation was previously reported for KCC4 and not for KCC2. Our study could identify specific 
glycosylation sites of KCC2. The exact functional role of each of these modifications will need to be further 
investigated.
This study describes the purification of homogenous, non-aggregated and functional native KCC2 using a 
calixarene-based detergent. These solubilizing and stabilizing compounds could facilitate the production of other 
challenging native membrane proteins such as GPCRs, transporters, ion channels or immunity proteins while 
maintaining their structural stability, homogeneity and functional integrities21,22,26,28. This study serves as a basis 
for the isolation of other membrane proteins of high importance to human health and for the discovery of novel 
Figure 9. KCC2 chemical crosslinking. Increasing amount of glutaraldehyde was added to purified KCC2 in 
presence or absence of DDT and analyzed by SDS-PAGE and Western-blot.
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compounds that could regulate the K+ Cl− co-transporter activity of KCC2. This work will also serve as a starting 
point for cryo-electron microscopy and functional investigations to better understand KCC2 functional domains 
and to help delineate common mechanistic features within the cation chloride cotransporters family. As such, this 
work could inform novel therapeutic routes for epilepsy, pain and schizophrenia treatment.
Experimental Procedures
KCC2 Construct generation. The following constructs were expressed from an in house vector featuring 
a CMV promoter derived from pcDNA 3.1: 1) wild type KCC2 corresponding to residues 1–1116 of NP_065759 
(human KCC2 isoform 2), 2) double tagged construct Flag-KCC2-His with additional DNA coding sequences for 
MDYKDDDDK added to the amino terminus and HHHHHHHHHH to the C-terminus (in pTT5), 3) 
N-terminal tagged Flag-Avi-His-KCC2 with coding sequence MGDYKDDDDKGGGLNDIF 
EAQKIEWHEGGHHHHHHHHHHGGG added to the N-terminus, and 4) C-terminal tagged KCC2-His-Avi-
Flag with coding sequence GGGHHHHHHHHHHGGGLNDIFEAQKIEWHEGGDYKDDDDKG added after 
residue 1116.
Transient transfection and cell culture. The various human KCC2 constructs were transfected 
into HEK293 cells using the MaxCyte STX electroporation. Expression of human KCC2 was confirmed by 
Western-blot using Rabbit anti-KCC2 as primary antibody (Sigma/Millipore #07-432). Culture media was 
DMEM (Sigma, D6546) with 10% FBS and 1% GlutaMAX (Gibco, 35050-038). For large scale production of 
protein for binding studies, suspension Expi293F cells were cultured in Expi293F media and transfected at high 
density with KCC2 plasmid DNA diluted to 1 mg/ml using PEIMax at 1 mg/ml38. Transfection was carried out on 
250 ml of suspension cells at 4 × 106/ml in vented 2 L capacity roller bottles shaken in an atmosphere of 5% CO2 at 
37 °C and 140 rpm in an orbital incubator (25 mm orbit). DNA and PEIMax were pre-incubated in E293F media 
for 15 minutes before adding to the cells. Twenty-four hours post transfection, cultures were fed with 50% media 
making 500 ml total volume per roller bottle and incubated for a further 48hrs. Cell pellets were harvested 72hrs 
post transfection by centrifugation at 10,000 × g for 20 min and stored at −80 °C prior to purification. Cells and 
media were purchased from ThermoScientific; 40 kDa linear PEI Max as hydrochloride salt (catalogue #24765) 
from Polysciences. Mouse KCC2 was expressed in HEK293 and N2a cells as previously described5,39–41.
Thallium assay. Following 48 hours incubation at 37 °C (5% CO2) cells were washed with HBSS (Hank’s 
Balanced Salt Solution). using a BioTek EL406 washer. Thallium assay buffer was made by diluting the Fluxor kit 
assay buffer (Life Tech #F10017) to 1X. Assay buffer was adjusted to pH 7.4 using NaOH. Loading buffer, which 
contained a fluorescent thallium sensitive dye (1000X), was formulated in a solution of Back Drop Suppressor 
Figure 10. Architecture of KCC2. (A) KCC2 dimer and monomer are represented in orange and green, 
respectively. Glutamate GABA anti-porter structure (PDB: 4DJK) and prokaryotic cation-chloride 
cotransporter (PDB: 3G4O) were filtered to 12 Å and fitted manually followed by optimization of the fit using 
UCSF Chimera. (B) Proposed fit of two monomers into a dimer. Two views are represented (blue and red 
correspond to Glutamate GABA anti-porter and prokaryotic cation-chloride cotransporter, respectively). In 
mesh colored in orange is represented the surface of KCC2 dimer reconstruction.
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(Life Tech #B10512) containing 10 µM bumetanide (Sigma #B3023) and 10 µM ouabain (Sigma #O3125) Cells 
were loaded with loading buffer using a Multidrop Combi After incubation at room temperature for 60 minutes, 
compounds were added using the FLIPR. Treatments consisted of DMSO (final conc. 0.5%), VU0463271 (32, 
10 µM final conc.) and N-ethylmaleimide (NEM, 100 µM final conc.) to see maximum thallium flux. Following 
a 90 minutes incubation at room temperature, thallium stimulus buffer was added to the cells on the FLIPR and 
thallium flux recorded for 220 seconds (ex. 515–575 nm). Data was analyzed using Screenworks v3.2 software 
(Molecular Devices). Maximum signal minus minimum signal between 1–120 seconds was used to compare 
groups.
Electrophysiology. Sensitivity to the specific KCC2 inhibitor VU046327131,32 was assessed in HEK293 cells 
transiently transfected (Lipofectamine 2000 reagent) with the cDNA for GFP, GlyR1, and either WT KCC2b, 
His-Avi-Flag-KCC2, KCC2-His-Avi-Flag, or Flag-KCC2-His. Cells were incubated for 48 h prior to recording. 
Cell culture medium was DMEM containing 10% FBS and 1% Pen/Strep and cells were grown in a 5% CO2 
atmosphere incubator at 37 °C. Recordings were conducted at room temperature (25 °C) in bath saline containing 
(in mM) NaCl 140, KCl 2.5, MgCl2 2.5, CaCl2 2.5, HEPES 10, glucose 11, pH 7.4 NaOH. Isolated GFP + HEK293 
cells were selected by epifluorescence and perforated with gramicidin (50 mg/ml) in a patch pipette contain-
ing (in mM) KCl 140, HEPES 10, pH 7.4 KOH. All chemicals were purchased from Sigma Aldrich (Pittsburgh, 
PA) and all cell culture reagents were purchased from Invitrogen (Carlsbad, CA). Solutions were applied with a 
three-barrel microperfusion system (700 µm, Warner Instruments, Hamden, CT) positioned closely above the 
cell. After establishing a series resistance of < 100 MΩ, bumetanide (10 µM) was added and a stable initial equi-
librium potential for glycine currents (EGLY) was found by application of glycine (50 µM) during positive-going 
voltage ramps (20 mV/1 s). The chloride concentrations were calculated with the Nerst equation, which relates 
observed equilibrium potential to concentrations of chloride on each side of the membrane. Because the outside 
concentration is controlled in the experiment, it can be solved for the internal concentration before and after 
application of VU0463271. Typically, EGLY was calculated using linear-regression fits to leak-subtracted currents. 
Next, VU0463271 (10 µM) was added with glycine pulses (50 µM, 3 s duration) applied every 20 s for a total of 
four minutes, after which a voltage ramp was used to calculate shifts in EGLY. Data were acquired at 10 kHz with 
an Axopatch 200B amplifier and Clampex 10 software (Molecular Devices, Sunnyvale, CA). Differences between 
treatments were assessed by one-way ANOVA with Dunnett’s multiple comparison tests comparing each shift to 
that observed in KCC2-WT expressing cells. Data are expressed as mean ± SEM.
Immunofluorescence Staining. HEK293 or Cos7 cells were plated on poly-L-lysine coated coverslips. 
Tagged KCC2 constructs were transfected into HEK293 or Cos7 cells using Lipofectamine 2000 reagent. After 
48 hours, cells were fixed in 4% paraformaldehyde. Cells were then washed in PBS and blocked for 1 hour at room 
temperature (5% BSA, 5% Normal Goat Serum, 0.1% Triton X-100 in PBS). Following blocking, coverslips were 
incubated with a KCC2 primary antibody (Millipore 07–432, diluted 1:200 in 2.5% BSA, 5% Normal Goat Serum, 
0.1% Triton X-100 in PBS) for 2 hours at room temperature. Coverslips were then washed in PBS and incu-
bated for 1 hour at room temperature with a goat anti-rabbit secondary antibody conjugated to Alexa Fluor 568 
(Invitrogen A-11036, diluted 1:500 in 2.5% BSA, 5% Normal Goat Serum, 0.1% Triton X-100 in PBS). Coverslips 
were then washed in PBS and mounted in ProLong Gold Antifade Reagent with DAPI (Life Technologies, 
P36931). Cells were imaged with a confocal microscope using a 60x objective. Identical laser settings were used 
when imaging constructs expressed in each cell type.
Membranes fractionation. Cells expressing mouse or human KCC2 were thawed on ice for 1 h with PBS 
(25 mM Na2HPO4, 150 mM NaCl, Protease Inhibitor Cocktail 1X. Mechanical cell lysis was performed on ice 
using a BeadBeater homogenizer with 0.1 mm diameter glass beads, including 5 pulses of 30 s with 2 minutes 
break in between. Membrane fractionation was carried out at 4 °C by sequential centrifugations: 1000 × g for 
5 min, 15000 × g for 30 min, and 100000 × g for 45 min. Internal (15000 × g fraction) and plasma membranes 
(100000 × g fraction) were resuspended in PBS, PIC 1X, 20% glycerol to a final concentration of 10 mg/ml, 
flash-frozen and stored at −80 °C.
Protein solubilization. Proteins from internal or plasma membrane fractions were incubated for 2 h at 4 °C 
at a final concentration of 5 mg/ml BCA in 1X PBS and 1X protease inhibitor cocktail, using different detergents 
conditions (classical and calixarenes based detergents CALX-R1 to R6, alone or in combination) at 10 CMC 
(Critical Micelle Concentration) for all compounds to be able to compare their solubilization power. Extraction 
without detergent and with SDS served as negative and positive controls, respectively. Dot blot analysis was per-
formed to evaluate the solubilization efficiency as described21. To confirm the results, solubilization was done 
again in similar condition using selected detergent, as well as increasing concentration of detergent. After solubi-
lization samples were centrifuged at 100000 x g for 45 min at 4 °C and an aliquot of the total extract, the pellet and 
the supernatant from each solubilization condition was analyzed by SDS-PAGE and Western-blot. Membranes 
prepared from N2a or HEK cells expressing mouse KCC2, were solubilized as described here.
Protein purification. His-tag affinity chromatography. The soluble protein fraction was loaded onto 
a TALON or Ni-NTA resin (40 μl of dry resin per mg of plasma membrane proteins). After 2 h incubation at 
4 °C, resin was washed with 10 Column Volumes (CV) of Wash Buffer 1 (PBS 1x; CALX-R3, 9 mM), Imidazole 
10 mM). Target protein was eluted with 4 times 3 CV of PBS 1x, DDM (0.6 mM), CALX-R3 (1.5 mM), with 
increasing concentration of Imidazole (20 mM, 50 mM, 100 mM, 250 mM). Samples of each fraction were ana-
lyzed by SDS-PAGE and Western-blot.
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Flag-affinity chromatography. A tandem affinity chromatography was applied (His-tag followed by Flag-tag). 
Elution fractions from His-affinity chromatography were loaded on anti-FLAG affinity resin (40 μl of either 50% 
suspension of Anti-Flag M2 magnetic or agarose beads per mg of plasma membrane proteins) and incubated 
overnight at 4 °C. Resin was then washed successively with 3 times 10 CV of PBS 1x, CALX-R3 (1.5 mM), DDM 
(0.6 mM), FLAG peptide 0.2 mg/ml. Samples of each fraction were analyzed by SDS-PAGE and Western-blot. 
When needed, the eluted protein was concentrated using Amicon ultra 100KDa flash-frozen in liquid nitrogen 
and stored at −80 °C until use.
Size exclusion chromatography. 50 μl of purified KCC2 at 1 mg/ml was loaded on a superdex 200 Increase 5/150 
GL(GE-Healthcare) at 0.1 ml/min. Running buffer was PBS 1x, CALX-R3 (1.5 mM), DDM (0.6 mM). Elution 
was performed at 0.1 ml/min with 1.5 CV of running buffer and 150 µl-fractions were collected. Fractions were 
analyzed by CN-PAGE and Western-blot.
SDS-PAGE and Western-blot. Purified hKCC2 was denatured with 5x Laemmli buffer and incubated for 
5 min at RT prior to analysis without heating to avoid aggregates formation. Proteins were separated by SDS-PAGE 
on a 4–15% acrylamide gel (4–15% Mini-PROTEAN® TGX Stain-Free™ Gel, Bio-Rad) and subsequently immobi-
lized by electro-transfer to PVDF membrane. The immunodetection of KCC2 was performed by using the SNAP i.d. 
system (Millipore) with either a primary goat anti-KCC2, a primary rabbit anti-phosphorylated S940, an anti-Flag 
horseradish peroxidase (HRP) conjugated or an anti-His HRP antibody, as specified in the text. Quantification of the 
signal was performed using Image Lab 4.1 software from Bio-Rad to calculate extraction efficiency.
Silver Stain/Coomassie Stain. SDS-PAGE were silver stained using Bio-Rad Dodeca Silver Stain Kit fol-
lowing supplier protocol or coomassie stained using the PageBlue™ protein staining solution.
Clear Native-PAGE (CN-PAGE) and Western-blot. Non-denaturated proteins were separated by 
Native-PAGE on a 4–15% acrylamide gel (4–15% Mini-PROTEAN® TGX Stain-Free™ Gel, Bio-Rad) using 
25 mM imidazole as anode buffer and 7.5 mM imidazole, 0.05% deoxycholate, 0.01% DDM as cathode buffer). 
Clear Native PAGE gels ran for 90 min at 200 V and 4 °C. Proteins were then immobilized by electro-transfer to 
PVDF membrane. The immunodetection of KCC2 was performed by using the SNAP i.d. system (Millipore) with 
either a primary goat anti-KCC2, an anti-Flag horseradish peroxidase (HRP) conjugated or an anti-His HRP 
antibody. For cryo-stability, aliquots of purified protein were submitted to freeze/thaw cycle in liquid nitrogen in 
absence of cryoprotectant then analyzed by CN-PAGE.
Protein quantification. Total protein concentrations in the plasma and the internal membrane fractions 
were determined with the micro BCA protein assay kit (Pierce) using the bovine serum albumin (BSA) as a 
standard.
Chemical crosslinking. Purified protein (5 µg) was submitted to crosslinking by addition of different 
concentration of glutaraldehyde 0, 0.01%, 0.02%,0.05%, 0.1% for 30 minutes at 4 °C. Samples were analyzed by 
SDS-PAGE and Western-blot.
Post-translational modifications of KCC2. Presence of the phosphorylation on the Serine S940 of puri-
fied KCC2 protein was detected by Western-blot using a primary specific antibody against KCC2 Phospho-serine 
940 (Interchim, #PLX360). Concerning glycosylation, purified KCC2 was subjected to deglycosylation using 
PNGase F (Glycopeptidase F) then analyzed by SDS-PAGE and Western-blot. SDS-PAGE bands containing gly-
cosylated and deglycosylated KCC2 were cut and analyzed by mass-spectrometry. Mass spectrometry analyses 
were performed as already described42. Raw files generated from mass spectrometry analysis were processed 
with Proteome Discoverer 1.4 (ThermoFisher Scientific). This software was used to search data via in-house 
Mascot server (version 2.4.1; Matrix Science Inc., London, UK) against the variant 27A- >V; 77R- >Q of KCC2 
isoform 2 added to the human subset (20, 160 sequences) of the SwissProt database (2016_10). Database searches 
were done using the following settings: a maximum of two trypsin miscleavages allowed; methionine oxidation, 
Serine/Threonine phosphorylation as variable modifications. A peptide mass tolerance of 6 ppm and a fragment 
mass tolerance of 0.8 Da were used for search analysis. Only peptides with high stringency Mascot score thresh-
old (identity, FDR < 1%) were selected and used for protein identification. PhosphoRS 3.0 tool was activated in 
ProteomeDiscoverer software to enable automated and confident localization of phosphorylation sites within 
validated peptides sequences.
Negative staining electron microscopy. Five microliters of purified KCC2 at 40 µg/ml (in gel filtration 
buffer, PBS 1x, CALX-R3 (1.5 mM), DDM (0.6 mM)) were adsorbed for 30 sec. on 200 Mesh copper grids coated 
with formvar-C and treated by a glow discharge in air for 2 min. The grids were stained with 2% uranyl ace-
tate for 1 min. A total of 2000 image frames were recorded for both the nomomer and the dimer fractions on a 
Transmission Electron Microscope (Tecnai F20 G2, FEI) equipped with a field emission gun operating at 200 kV 
at a magnification of 66.000 x, on a 2048 × 2048 CCD camera (Ultrascan 1000, Gatan Inc., Pleasanton) with a final 
pixel spacing on the specimen of 0.212 nm. Particles were selected manually using the Boxer application in the 
EMAN software package43. Two-dimensional class averages were calculated using the Relion software package44 
and further used to extract automatically the particle images. After several rounds of image sorting 78,781 dimer 
and 114,370 monomer particles were selected, aligned, clustered into different classes and class averages were cal-
culated. The SIMPLE software45 was used to generate a starting 3-D model which was further refined with Relion 
using standard procedures. Figures were prepared using UCSF Chimera46.
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Surface Plasmon Resonance (SPR) binding experiments. The experiments were performed on a 
Biacore S200 optical biosensor unit (GE Healthcare) at 10 °C using sensor chips Series S NTA (Research grade). 
The running buffer was composed of 10 mM HEPES, 150 mM NaCl, 0.1% (w/v) DDM, 0.0024%(w/v) CHS, 
0.012%(w/v) CHAPS, pH 7.4 and was delivered at a flow-rate of 20 µl/min. Prior to covalent tethering of KCC2 
protein, the surface was conditioned by 1 min injection 10 µM NiCl2. The surface was activated for 7 min with 
50 mM NHS and 200 mM EDC and the flowrate was subsequently reduced to 1 µl/min. KCC2 protein at a final 
concentration of 300 µg/mL was injected over the surface with a contact time of 20 min resulting in a final den-
sity of approximately 4000 RU. The reference surface was prepared identically with the exception of no protein 
added. The ligand binding experiments were performed at a flow rate of 30 µl/min using multi-cycle kinetics. The 
antagonist VU0463271 and negative control compounds was injected in concentration response experiments 
using a 3-fold dilution series at 0.5% DMSO. The equilibrium dissociation constant was determined by non-linear 
regression analysis of the steady-state SPR signals as a function of ligand concentration using the Langmuir iso-
therm equation.
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